FDA Inspection 914703 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567004

The FDA completed an inspection of Regenerative Biologics, Inc. on February 19, 2015 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)